U.S. Markets open in 87 hrs, 46 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,543.55 | -171.63 | -1.47% |
| NASDAQ | 2,367.52 | -44.12 | -1.83% |
| S&P 500 | 1,282.83 | -17.85 | -1.37% |
| Day Low 03:54 PM EDT | 94.06 | |
|---|---|---|
| Day High 09:44 AM EDT | 95.98 |
|
| Range | 1.92 | |
| Volume | 335,770 | |
| 30-Day Avg. Vol. | 549,000 |
|
| Difference | -38.84% | |
| Market Cap. | 5.94 B | |
| Change | -100.84 M | |
| Shares Out. | 63.02 M | |
| Percent Traded | 0.53% | |
| Revenue | 1.63 B | |
| Earnings | 175.92 M | |
| EPS (TTM) | 3.03 |
| 52-Wk Low 8/29/07 | 71.43 | |
|---|---|---|
| 52-Wk High 8/7/08 | 99.08 |
|
| Range | 27.65 | |
| Prev. Close 8/28/08 | 95.94 | |
| Today's Open | 95.77 | |
| Change | -0.18% | |
| Dividend (TTM) | 0.00 | |
| Div. Yield (TTM) | 0.00% |
|
| Beta | 0.1447 | |
| P/E Ratio (TTM) | 31.14 | |
| P/E Ratio (Fwd.) | 27.00 |
Behind every great drug company stands a great contract research organization (CRO), and Covance is one of the biggest. Covance helps pharmaceutical and biotech companies develop new drugs, providing preclinical ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | 0.73 3/31/08 | 0.73 3/31/08 |
0.00
Met
|
| Last Quarter | 0.783 6/30/08 | 0.79 6/30/08 |
0.007
Beat
|
| Quarterly - 06/30/2008 | Annual - 2007 | |
|---|---|---|
| Total Revenue | 461.82 M | 1.63 B |
| Gross Profit | 132.70 M | 462.54 M |
| Operating Income | 67.46 M | 228.65 M |
| Net Income | 50.87 M | 175.93 M |
Real-Time Quote
